世界の転移性骨がんの薬物治療市場：市場規模・現状・予測

• 英文タイトル：Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7552
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、転移性骨がんの薬物治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの薬物治療の世界市場規模
・主要企業別市場シェア
・転移性骨がんの薬物治療の世界市場規模：種類別（）
・転移性骨がんの薬物治療の世界市場規模：用途別（）
・転移性骨がんの薬物治療のアメリカ市場規模（種類別、用途別）
・転移性骨がんの薬物治療のヨーロッパ市場規模（種類別、用途別）
・転移性骨がんの薬物治療の中国市場規模（種類別、用途別）
・転移性骨がんの薬物治療の日本市場規模（種類別、用途別）
・転移性骨がんの薬物治療の東南アジア市場規模（種類別、用途別）
・転移性骨がんの薬物治療のインド市場規模（種類別、用途別）
・転移性骨がんの薬物治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・転移性骨がんの薬物治療の世界市場予測（2019年-2025年）
・転移性骨がんの薬物治療の地域別市場予測（2019年-2025年）
...

Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Cancer Medication Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metastatic Bones Cancer Medication Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Bones Cancer Medication Treatment development in United States, Europe and China.

The key players covered in this study
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic

Market segment by Type, the product can be split into
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metastatic Bones Cancer Medication Treatment status, future forecast, growth opportunity, key market and key players.
To present the Metastatic Bones Cancer Medication Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metastatic Bones Cancer Medication Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastatic Bones Cancer Medication Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Hormone Therapy
1.4.4 Bisphosphonates
1.4.5 Opiate Therapy
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metastatic Bones Cancer Medication Treatment Market Size
2.2 Metastatic Bones Cancer Medication Treatment Growth Trends by Regions
2.2.1 Metastatic Bones Cancer Medication Treatment Market Size by Regions (2014-2025)
2.2.2 Metastatic Bones Cancer Medication Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metastatic Bones Cancer Medication Treatment Market Size by Manufacturers
3.1.1 Global Metastatic Bones Cancer Medication Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastatic Bones Cancer Medication Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Metastatic Bones Cancer Medication Treatment Key Players Head office and Area Served
3.3 Key Players Metastatic Bones Cancer Medication Treatment Product/Solution/Service
3.4 Date of Enter into Metastatic Bones Cancer Medication Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019)
4.2 Global Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
5.2 Metastatic Bones Cancer Medication Treatment Key Players in United States
5.3 United States Metastatic Bones Cancer Medication Treatment Market Size by Type
5.4 United States Metastatic Bones Cancer Medication Treatment Market Size by Application

6 Europe
6.1 Europe Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
6.2 Metastatic Bones Cancer Medication Treatment Key Players in Europe
6.3 Europe Metastatic Bones Cancer Medication Treatment Market Size by Type
6.4 Europe Metastatic Bones Cancer Medication Treatment Market Size by Application

7 China
7.1 China Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
7.2 Metastatic Bones Cancer Medication Treatment Key Players in China
7.3 China Metastatic Bones Cancer Medication Treatment Market Size by Type
7.4 China Metastatic Bones Cancer Medication Treatment Market Size by Application

8 Japan
8.1 Japan Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
8.2 Metastatic Bones Cancer Medication Treatment Key Players in Japan
8.3 Japan Metastatic Bones Cancer Medication Treatment Market Size by Type
8.4 Japan Metastatic Bones Cancer Medication Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
9.2 Metastatic Bones Cancer Medication Treatment Key Players in Southeast Asia
9.3 Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size by Type
9.4 Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size by Application

10 India
10.1 India Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
10.2 Metastatic Bones Cancer Medication Treatment Key Players in India
10.3 India Metastatic Bones Cancer Medication Treatment Market Size by Type
10.4 India Metastatic Bones Cancer Medication Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Metastatic Bones Cancer Medication Treatment Market Size (2014-2019)
11.2 Metastatic Bones Cancer Medication Treatment Key Players in Central & South America
11.3 Central & South America Metastatic Bones Cancer Medication Treatment Market Size by Type
11.4 Central & South America Metastatic Bones Cancer Medication Treatment Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastatic Bones Cancer Medication Treatment Introduction
12.1.4 Amgen Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Merck & Co
12.2.1 Merck & Co Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastatic Bones Cancer Medication Treatment Introduction
12.2.4 Merck & Co Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.2.5 Merck & Co Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastatic Bones Cancer Medication Treatment Introduction
12.3.4 Roche Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastatic Bones Cancer Medication Treatment Introduction
12.4.4 Novartis Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastatic Bones Cancer Medication Treatment Introduction
12.5.4 Eli Lilly and Company Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastatic Bones Cancer Medication Treatment Introduction
12.6.4 Bayer Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastatic Bones Cancer Medication Treatment Introduction
12.7.4 Fresenius Kabi Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.7.5 Fresenius Kabi Recent Development
12.8 BTG plc
12.8.1 BTG plc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastatic Bones Cancer Medication Treatment Introduction
12.8.4 BTG plc Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.8.5 BTG plc Recent Development
12.9 Boston Scientific
12.9.1 Boston Scientific Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metastatic Bones Cancer Medication Treatment Introduction
12.9.4 Boston Scientific Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.9.5 Boston Scientific Recent Development
12.10 Medtronic
12.10.1 Medtronic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metastatic Bones Cancer Medication Treatment Introduction
12.10.4 Medtronic Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
12.10.5 Medtronic Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metastatic Bones Cancer Medication Treatment Key Market Segments
Table Key Players Metastatic Bones Cancer Medication Treatment Covered
Table Global Metastatic Bones Cancer Medication Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figure Opiate Therapy Figures
Table Key Players of Opiate Therapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Table Global Metastatic Bones Cancer Medication Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Metastatic Bones Cancer Medication Treatment Report Years Considered
Table Global Metastatic Bones Cancer Medication Treatment Market Size 2014-2025 (Million US$)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Share by Regions 2014-2019
Figure Global Metastatic Bones Cancer Medication Treatment Market Share by Regions 2014-2019
Figure Global Metastatic Bones Cancer Medication Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Metastatic Bones Cancer Medication Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Share by Manufacturers (2014-2019)
Figure Global Metastatic Bones Cancer Medication Treatment Market Share by Manufacturers in 2018
Table Global Metastatic Bones Cancer Medication Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metastatic Bones Cancer Medication Treatment Product/Solution/Service
Table Date of Enter into Metastatic Bones Cancer Medication Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Size Share by Type (2014-2019)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size Market Share by Type (2014-2019)
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Metastatic Bones Cancer Medication Treatment Market Size Share by Application (2014-2019)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size Market Share by Application (2014-2019)
Figure Global Metastatic Bones Cancer Medication Treatment Revenue Market Share by Application in 2018
Figure United States Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table United States Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table United States Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure Europe Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table Europe Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table Europe Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure China Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table China Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-20189) (Million US$)
Table China Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table China Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table China Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure Japan Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table Japan Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table Japan Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure India Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table India Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table India Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table India Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table India Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Figure Central & South America Metastatic Bones Cancer Medication Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metastatic Bones Cancer Medication Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metastatic Bones Cancer Medication Treatment Market Share (2018-2019)
Table Central & South America Metastatic Bones Cancer Medication Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metastatic Bones Cancer Medication Treatment Market Share by Type (2014-2019)
Table Central & South America Metastatic Bones Cancer Medication Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metastatic Bones Cancer Medication Treatment Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Amgen Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Merck & Co Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Merck & Co Recent Development
Table Roche Company Details
Table Roche Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Bayer Company Details
Table Bayer Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Bayer Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Fresenius Kabi Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Fresenius Kabi Recent Development
Table BTG plc Company Details
Table BTG plc Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure BTG plc Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table BTG plc Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Boston Scientific Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Metastatic Bones Cancer Medication Treatment Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Metastatic Bones Cancer Medication Treatment Business (2014-2019)
Table Medtronic Recent Development
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Metastatic Bones Cancer Medication Treatment Market Size Share by Regions (2019-2025)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size Share by Regions in 2025
Figure United States Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metastatic Bones Cancer Medication Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size by Product (2019-2025)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size by Product in 2025
Table Global Metastatic Bones Cancer Medication Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size by Application (2019-2025)
Figure Global Metastatic Bones Cancer Medication Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の転移性骨がん市場：市場規模・現状・予測

Global Metastatic Bones Cancer Market Size, Status and Forecast 2019-2025
QYR9N7551 2019年6月14日 94Pages
当資料は、転移性骨がんのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの世界市場規模
・主...

世界の転移性骨疾患の治療市場：市場規模・現状・予測

Global Medication Treatment of Metastatic Bone Disease Market Size, Status and Forecast 2019-2025
QYR9N7531 2019年6月14日 93Pages
当資料は、転移性骨疾患の治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨疾患の治療の世界市場規模

世界の転移性乳がんの治療市場：市場規模・現状・予測

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7553 2019年6月14日 96Pages
当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の転移性大腸がんの治療市場：市場規模・現状・予測

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7555 2019年6月14日 95Pages
当資料は、転移性大腸がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、化学療法）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の転移性結腸直腸がん手術市場：市場規模・現状・予測

Global Metastatic Colorectal Cancer Surgery Market Size, Status and Forecast 2019-2025
QYR9N7554 2019年6月14日 98Pages
当資料は、転移性結腸直腸がん手術のグローバル市場について調査・分析したレポートで、種類別（腫瘍の切除、門脈塞栓術）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の男性の乳がんの治療市場：市場規模・現状・予測

Global Male Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7498 2019年6月14日 99Pages
当資料は、男性の乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（薬、化学療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界の転移性骨疾患市場：市場規模・現状・予測

Global Metastatic Bone Disease Market Size, Status and Forecast 2019-2025
QYR9N7550 2019年6月14日 96Pages
当資料は、転移性骨疾患のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨疾患の世界市場規模
・主...

世界の非血液がん治療市場：市場規模・現状・予測

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7684 2019年6月14日 94Pages
当資料は、非血液がん治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、手術、放射線療法、その他）、用途別（病院、腫瘍治療センター、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...

世界の口腔がんの治療市場：市場規模・現状・予測

Global Oral Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7715 2019年6月14日 98Pages
当資料は、口腔がんの治療のグローバル市場について調査・分析したレポートで、種類別（扁平上皮がん、疣状がん、小唾液腺がん、リンパ腫）、用途別（病院と診療所、研究機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測

Global Non-Melanoma Skin Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7688 2019年6月14日 101Pages
当資料は、非黒色腫皮膚がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、光線力学療法）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界の転移性骨がん市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
世界の転移性骨疾患の治療市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Medication Treatment of Metastatic Bon…
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…